Mediating MDMA-related harm: Preloading and post-loading among ecstasy-using youth

Journal of Psychoactive Drugs

Volumn 41, Issue 1, 2009, Pages 19-26

  Kelly, Brian C ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Club drugs; Ecstasy; Harm reduction; Post loading; Pre loading; Youth

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ASCORBIC ACID; GINKGO BILOBA EXTRACT; HYPERICUM PERFORATUM EXTRACT; MULTIVITAMIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; DRUG ADMINISTRATION ROUTE; ETHNOPHARMACOLOGY; FEMALE; FOOD DRUG INTERACTION; HARM REDUCTION; HIGH RISK BEHAVIOR; HUMAN; MALE; NEUROTOXICITY; NUTRITIONAL SUPPORT; ORANGE JUICE; PARTICIPANT OBSERVATION; RISK REDUCTION; SEMI STRUCTURED INTERVIEW; SOCIAL BEHAVIOR; SOCIOPATHY; SUBSTANCE ABUSE; UNITED STATES;

EID: 65649099092     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2009.10400671     Document Type: Article

References (48)

1. Allott, K. & Redman, J. 2006. Patterns of use and harm reduction practices of Ecstasy users in Australia. Drug & Alcohol Dependence 82: 168-76.
2. Akram, G. & Galt, M. 1999. A profile of harm-reduction practices and co-use of illicit and licit drugs amongst users of dance drugs. Drugs-Education Prevention & Policy 6: 215-25.
3. Baggott, M. & Mendelson, J. 2001. Does MDMA cause brain damage? In: J. Holland (Ed.) Ecstasy: The Complete Guide. Rochester, VT: Park Street Press.
4. Barrett, S.P.; Gross, S.R.; Garand, I. & Pihl, R.O. 2005. Patterns of simultaneous polysubstance use in Canadian rave attendees. Substance Use & Misuse 40: 1525-37.
5. Bogt, T.M.T. & Engels, R.C.M.E. 2005. "Partying” hard: Party style, motives, and effects of MDMA use at rave parties. Substance Use & Misuse 40: 1479-1502.
6. Chang, L.; Grob, C.S., Ernst, T.; Itti, L.; Mishkin, F.S.; Jose-Melchor, R. & Poland R.E. 2000. Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: A co-registered SPECT and MRI study Psychiatry Research: Neuroimaging 98: 15-28.
7. Community Epidemiology Work Group (CEWG). 2001. Epidemiologic Trends in DrugAbuseAdvanceReport, June 2001. Available at: http://www.nida.nih.gov/CEWG/AdvancedRep/60 1 ADV/601 adv.html
8. Copeland, J.; Dillon, P. & Gascoigne, M. 2005. Ecstasy and the concomitant use of pharmaceuticals. Addictive Behaviors 31: 367-70.
9. Curran, H.V. & Travill, R.A. 1997. Mood and cognitive effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy”): Week-end "high” followed by mid-week low. Addiction 92: 821-31.
10. de Win, M.M.L.; Reneman, L.; Reitsma, J.B.; den Heeten, G.J.; Booij, J. & van den Brink, W. 2004. Mood disorders and serotonin transporter density in Ecstasy users— The influence of long-term abstention, dose, and gender. Psychopharmacology 173: 376-82.
11. Degenhardt, L.; Copeland, J. & Dillon, P. 2005. Recent trends in the use of "club drugs”: An Australian review. Substance Use & Misuse 40: 1241-56.
12. Degenhardt, L.; Barker, B. & Topp, L. 2004. Patterns of Ecstasy use in Australia: Findings from a national household survey. Addiction 99 (2): 187-95.
13. Falck, R.S.; Wang, J.; Carlson, R.G. & Siegal, H.A. 2006. Prevalence and correlates ofcurrent depressive symptomatology among a community sample of MDMA users in Ohio. Addictive Behaviors 31: 90-101.
14. Gamma, A.; Jerome, L.; Liechti, M.E. & Sumnall, H.R. 2005. Is Ecstasy perceived to be safe? A critical survey. Drug & Alcohol Dependence 77: 185-93.
15. Geertz, C. 1983. Local Knowledge: Further Essays in Interpretive Anthropology. New York: Basic Books.
16. Halpern, J.H.; Pope, H.G.; Sherwood, A.R.; Barry, S.; Hudson, J.l. & Yurgelun-Todd, D. 2004. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug & Alcohol Dependence 75: 135-47.
17. Holland, J. 2001. Minimizing risk in the dance community: An interview with Emanual Sferios In: J. Holland (Ed.) Ecstasy: The Complete Guide. Rochester, VT: Park Street Press.
18. Jayanthi, S.; Ladenheim, B.; Andrews, A.M. & Cadet, J.L. 1999. Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methelyenedioxymethamphetamine (Ecstasy). Neuroscience 91: 1379-87.
19. Johnston, L.D.; O'Malley, P.M. & Bachman, J.G. 2002. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2001. Bethesda, MD: National Institute on Drug Abuse.
20. Kelly, B.C. 2007. Club drug use and risk management among "Bridge and Tunnel” youth. Journal of Drug Issues 37: 425-44.
21. Kelly, B.C. 2005. Conceptions of risk among club drug-using youth. Substance Use and Misuse 40: 1443-59.
22. Leonard, L. & Ross, M. 1997. The last sexual encounter: The contextualization of sexual risk behaviour. International Journal of STD & AIDS 8: 643-45.
23. Malberg, J.E.; Sabol, K.E. & Seiden, L.S. 1996. Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. Journal of Pharmacology and Experimental Therapeutics 278: 258-67.
24. McCann, U.D.; Szabo, S.; Scheffel, U.; Dannals, R.F. & Ricaurte, G.A. 1998. Positron emission tomographic evidence of toxic effect of MDMA (Ecstasy) on brain serotonin neurons in human beings. Lancet 352: 1433-37.
25. Morgan, M.J. 1998. Recreational use of"ecstasy” (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19: 252-64.
26. Oesterheld, J.R.; Armstrong, S.C. & Cozza, K.L. 2004. Ecstasy: Pharmacodynamic and pharmacokinetic interactions. Psychosomatics 45: 84-87.
27. O'Shea, E.; Granados, R.; Esteban, B.; Colado, M.I. & Green, A.R. 1998. The relationship between the degree on neurodigestion of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (ecstasy). Neuropharmacology 37: 919-26.
28. Parrott, A.C. & Lasky, J. 1998. Ecstasy (MDMA) effects upon mood and cognition: Before, during and after a Saturday night dance. Psychopharmacology 139: 261-68.
29. Parrott, A.C.; Buchanan, T.; Scholey, A.B.; Heffernan, T.; Ling, J. & Rodgers, J. 2002. Ecstasy/MDMA attributed problems reported by novice, moderate, and heavy recreational users. Human Psychopharmacology 17: 309-12.
30. Rodgers, J. 2000. Cognitive performance amongst recreational users of "ecstasy.” Psychopharmacology 151: 19-24.
31. Roiser, J.P. & Sahakian, B.J. 2004. Relationship between Ecstasy use and depression: A study controlling for poly-drug use. Psychopharmacology 173: 411-17.
32. Rosenbaum, M. 2002. Ecstasy: America’s new "Reefer Madness.” Journal of Psychoactive Drugs 34 (2): 1-9.
33. Sanjek, R. 1990. Fieldnotes: The Making of Anthropology. Ithaca, NY: Cornell University Press.
34. Shankaran, M.; Yamomoto, B.K. & Gudelsky, G.A. 2001. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT. Synapse 40: 55-64.
35. Shankaran, M.; Yamamoto, B.K & Gudelsky, G.A. 1999. Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethampheta^ine. European Journal of Pharmacology 385: 103-10
36. Simon, N.G. & Mattick, R.P. 2002. The impact of regular Ecstasy use on memory function. Addiction 97: 15-23.
37. Soellner, R. 2005. Club drug use in Germany. Substance Use & Misuse 40: 1279-93.
38. Southgate, E. & Hopwood, M. 2001. The role of folk pharmacology and lay experts in harm reduction: Sydney gay drug using networks. International Journal of Drug Policy 12: 321-35.
39. Sprague, J.E.; Huang, X.; Kanthasamy, A. & Nichols, D.E. 1994. Attenuation of 3,4-methylenedioxymethamphetamine (MDMA) induced neurotoxicity with the serotonin precursors tryptophan and 5-hydroxytryptophan. Life Sciences 55: 1193-98.
40. Strauss, A. & Corbin, J. 1998. Basics of Qualitative Research: Grounded Theory Procedures and Techniques. Second Edition. Newbury Park, CA: Sage Publications.
41. Substance Abuse and Mental Health Services Administration (SAMHSA). 2006. Results from the 2005 National Survey on Drug Use and Health: National Findings. NSDUH Series H-30, DHHS Publication No. SMA 06-4194. Rockville, MD: Office ofApplied Studies.
42. SubstanceAbuse and Mental Health Services Administration (SAMHSA). 2002. Results from the 2001 National Household Survey on Drug Abuse: Volume I. Summary of National Findings. NHSDA Series H-17, DHHS Publication No. SMA02-3758. Rockville, MD: Office of Applied Studies.
43. Thornton, S. 1995. Club Cultures: Music, Media, and Subcultural Capital. Hanover, NH: Wesleyan University Press.
44. Topp, L.; Hando, J.; Dillon, P.; Roche, A. & Solowij, N. 1999. Ecstasy use in Australia: Patterns of use and associated harm. Drug & Alcohol Dependence 55: 105-15.
45. Travers, K.R. & Lyvers, M. 2005. Mood and impulsivity of recreational Ecstasy users in the week following a "rave.” Addiction Research & Theory 13: 43-52.
46. Vollenweider, F.X.; Gamma, A.; Liechti, M. & Huber, T. 1999. Is a single dose of MDMA harmless? Neuropsychopharmacology 21: 598-600.
47. Wareing, M.; Fisk, J.E.; Murphy, P. & Montgomery, C. 2005. Visuo-spatial working memory deficits in current and former users of MDMA (‘ecstasy’). Human Psychopharmacology: Clinical & Experimental 20: 115-23.
48. Yip, J.T.H. & Lee, T.M.C. 2005. Effect ofEcstasy use on neuropsychological function: A study in Hong Kong. Psychopharmacology 179: 620-28.